Clinical trial
Phase 1 Evaluation of Novel Imaging Diagnostic Agent NeuCaVis in Healthy Volunteers
NCT07253753 is registered in ClinicalTrials.gov with Yellowbird Diagnostics Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Evaluation of Novel Imaging Diagnostic Agent NeuCaVis in Healthy Volunteers
- Lead sponsor
- Yellowbird Diagnostics Inc
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 8, 2026
- Completion date
- June 17, 2026
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy